COVID-19: ACT trials for colchicine and antithrombotic therapies

被引：2
|
作者：
Barco, Stefano [1 ,2 ]
Schreiber, Karen [3 ,4 ,5 ]
机构：
[1] Univ Hosp Zurich, Dept Angiol, CH-8091 Zurich, Switzerland
[2] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany
[3] Univ Southern Denmark, Danish Hosp Rheumat Dis, Sonderborg, Denmark
[4] Univ Southern Denmark, Dept Reg Hlth Res IRS, Odense, Denmark
[5] Guys & St Thomas NHS Fdn Trust, Thrombosis & Haemostasis, London, England
来源：
LANCET RESPIRATORY MEDICINE | 2022年 / 10卷 / 12期
关键词：
OPEN-LABEL; MULTICENTER; OUTPATIENTS;
D O I：
10.1016/S2213-2600(22)00368-X
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1106 / 1108
页数：4
相关论文
共 50 条
  • [31] ISTH guidelines for antithrombotic treatment in COVID-19
    Lampl, Benedikt
    PHLEBOLOGIE, 2023, 52 (02) : 69 - 69
  • [32] ISTH guidelines for antithrombotic treatment in COVID-19
    Schulman, Sam
    Sholzberg, Michelle
    Spyropoulos, Alex C.
    Zarychanski, Ryan
    Resnick, Helaine E.
    Bradbury, Charlotte A.
    Broxmeyer, Lisa
    Connors, Jean Marie
    Falanga, Anna
    Iba, Toshiaki
    Kaatz, Scott
    Levy, Jerrold H.
    Middeldorp, Saskia
    Minichiello, Tracy
    Ramacciotti, Eduardo
    Samama, Charles Marc
    Thachil, Jecko
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (10) : 2214 - 2225
  • [33] Effect of colchicine on clinical outcomes in COVID-19
    Abdenneji, S.
    Fekih, W.
    Ben Krayen, I.
    El Ghoul, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [34] COVID-19 cardiac injury and the use of colchicine
    Anton-Vazquez, Vanesa
    Byrne, Laura
    Anderson, Lisa
    Hamzah, Lisa
    BMJ CASE REPORTS, 2021, 14 (02)
  • [35] Colchicine in the management of Covid-19: With or lieu of evidence
    Al-Kuraishy, Hayder Mutter
    Hussien, Nawar Raad
    Al-Niemi, Marwa Salih
    Al-Gareeb, Ali Ismail
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (12) : S127 - S132
  • [36] Use of colchicine in COVID-19 hospitalized patients
    Korra, Emad E. A.
    AbdelFattah, Eman B.
    Ahmed, Mervat A.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2022, 71 (03): : 290 - 295
  • [37] Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials
    Talasaz, Azita H.
    Sadeghipour, Parham
    Aghakouchakzadeh, Maryam
    Kakavand, Hessam
    Ariannejad, Hamid
    Connors, Jean M.
    Hunt, Beverley J.
    Berger, Jeffrey S.
    Van Tassell, Benjamin W.
    Middeldorp, Saskia
    Piazza, Gregory
    Weitz, Jeffrey, I
    Cushman, Mary
    Lip, Gregory Y. H.
    Goldhaber, Samuel Z.
    Bikdeli, Behnood
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (12) : 3080 - 3089
  • [38] Potential specific therapies in COVID-19
    Gul, Muhammad Hamdan
    Htun, Zin Mar
    Shaukat, Nauman
    Imran, Muhammad
    Khan, Ahmad
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [39] Therapies Curtailed by the COVID-19 Pandemic
    Sklar, Jamie
    Rapoport, Eli
    Milanaik, Ruth
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2022, 43 (02): : E138 - E139
  • [40] An Analysis of Antioxidant Therapies for COVID-19
    Holt, Alan
    Davies, Adrian
    ADVANCED THEORY AND SIMULATIONS, 2023, 6 (12)
12345